Reckitt Benckiser Group (RBGLY) Expected to Announce Quarterly Earnings on Thursday

Key Points

• Reckitt Benckiser Group is set to report quarterly results before the market opens on Thursday, March 5, with analysts forecasting $0.5110 EPS and $9.849 billion in revenue.
• The stock traded at $16.28 on Tuesday (volume 35,939), sitting near its 50‑day moving average of $16.80 and one‑year high of $16.80, while liquidity and balance‑sheet metrics are weak (quick ratio 0.37, current ratio 0.56) with a debt‑to‑equity of 1.01.
• Wall Street sentiment is mixed but tilted positive, with a consensus rating of Moderate Buy (2 Strong Buy, 1 Buy, 4 Hold).

Reckitt Benckiser Group (OTCMKTS:RBGLY - Get Free Report) will likely be releasing its results before the market opens on Thursday, March 5th. Analysts expect Reckitt Benckiser Group to post earnings of $0.5110 per share and revenue of $9.8490 billion for the quarter.

Reckitt Benckiser Group Price Performance

Shares of RBGLY traded down $0.18 during mid-day trading on Tuesday, hitting $16.28. The company's stock had a trading volume of 35,939 shares, compared to its average volume of 504,240. The stock's 50-day moving average is $16.80 and its two-hundred day moving average is $15.95. The company has a quick ratio of 0.37, a current ratio of 0.56 and a debt-to-equity ratio of 1.01. Reckitt Benckiser Group has a one year low of $11.99 and a one year high of $16.80.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on RBGLY shares. Jefferies Financial Group restated a "hold" rating on shares of Reckitt Benckiser Group in a research report on Wednesday, January 7th. Royal Bank Of Canada cut shares of Reckitt Benckiser Group from an "outperform" rating to a "sector perform" rating in a research note on Wednesday, January 14th. Citigroup started coverage on Reckitt Benckiser Group in a research note on Wednesday, January 14th. They set a "buy" rating on the stock. Morgan Stanley cut Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a report on Monday, December 15th. Finally, Barclays raised Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a report on Monday, December 1st. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy".

About Reckitt Benckiser Group

Reckitt Benckiser Group plc is a multinational consumer goods company that develops, manufactures and markets health, hygiene and home products. Its portfolio spans over-the-counter medicines and health products, personal and sexual wellness, surface and laundry cleaning, and household care. The company owns a number of well-known global brands across these categories, including Lysol and Dettol in disinfectants and hygiene, Durex in sexual wellness, Nurofen in analgesics, and Finish in dishwashing products.

The firm has its corporate headquarters in the United Kingdom and sells products in markets around the world, serving consumers across North America, Europe, Asia, Latin America, the Middle East and Africa.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.